Zhejiang Medicine Co., Ltd. (SHA: 600216)
China flag China · Delayed Price · Currency is CNY
17.70
-0.19 (-1.06%)
Nov 13, 2024, 3:00 PM CST

Zhejiang Medicine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
17,02110,28111,20316,36813,03312,793
Upgrade
Market Cap Growth
55.62%-8.23%-31.56%25.59%1.87%52.82%
Upgrade
Enterprise Value
16,0759,75210,75115,88612,61112,289
Upgrade
Last Close Price
17.7010.5911.3616.2212.7311.89
Upgrade
PE Ratio
17.3023.6720.2814.8816.9733.03
Upgrade
PS Ratio
1.871.321.381.791.781.82
Upgrade
PB Ratio
1.651.031.151.781.621.55
Upgrade
P/FCF Ratio
60.15-63.24-24.6083.0618.07-101.23
Upgrade
P/OCF Ratio
18.1916.2121.5214.4010.3728.60
Upgrade
EV/Sales Ratio
1.781.251.321.741.721.74
Upgrade
EV/EBITDA Ratio
11.7215.239.189.099.8416.25
Upgrade
EV/EBIT Ratio
22.05-537.3021.9513.6916.2245.77
Upgrade
EV/FCF Ratio
56.81-59.99-23.6180.6217.48-97.24
Upgrade
Debt / Equity Ratio
0.070.080.090.050.120.08
Upgrade
Debt / EBITDA Ratio
0.551.300.710.270.740.86
Upgrade
Debt / FCF Ratio
2.65-5.12-1.832.421.32-5.14
Upgrade
Asset Turnover
0.690.620.650.790.700.69
Upgrade
Inventory Turnover
2.952.692.813.303.033.25
Upgrade
Quick Ratio
1.701.391.401.301.821.69
Upgrade
Current Ratio
2.612.262.292.002.662.46
Upgrade
Return on Equity (ROE)
8.33%2.81%3.84%10.28%8.10%3.57%
Upgrade
Return on Assets (ROA)
3.50%-0.09%2.45%6.30%4.66%1.64%
Upgrade
Return on Capital (ROIC)
4.13%-0.11%3.03%7.78%5.43%1.92%
Upgrade
Earnings Yield
5.78%4.18%4.82%6.39%5.50%2.68%
Upgrade
FCF Yield
1.66%-1.58%-4.07%1.20%5.54%-0.99%
Upgrade
Dividend Yield
0.84%1.42%1.50%2.04%1.81%8.41%
Upgrade
Payout Ratio
17.48%44.67%65.07%24.88%140.26%49.01%
Upgrade
Buyback Yield / Dilution
2.50%0.31%-0.47%-0.26%-0.46%0.75%
Upgrade
Total Shareholder Return
3.34%1.73%1.03%1.78%1.35%9.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.